Archive

  • M&G Catalyst impact strategy invests in vaccine developer

    18 March 2021

    M&G was lead investor in a funding round worth $168 million in Vaccitech, which co-invented a Covid-19 vaccine with the University of Oxford.

  • Liontrust identifies healthcare companies profiting from coronavirus response

    14 April 2020

    Liontrust Asset Management has identified some of the healthcare companies that can play a part in responding to the Covid-19 outbreak, while acknowledging the "morally difficult" implications of profiting from the pandemic.